These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 13289749)
1. [Prothrombin-forming function of the liver and hemorrhagic syndrome in thyrotoxicosis]. ALEKPEROV MA Probl Endokrinol Gormonoter; 1955; 1(4):33-6. PubMed ID: 13289749 [No Abstract] [Full Text] [Related]
2. Liver function in thyrotoxicosis; studies on the cholesterol and prothrombin level in the blood during the treatment of thyrotoxicosis. LAMBERG BA; GORDIN R Acta Endocrinol (Copenh); 1954 Jan; 15(1):82-96. PubMed ID: 13137858 [No Abstract] [Full Text] [Related]
5. [Hemorrhagic diathesis in the course of regulation disorders of the hemopoietic system]. HANICKI Z Pol Arch Med Wewn; 1955; 25(1a):191-3. PubMed ID: 14394919 [No Abstract] [Full Text] [Related]
6. [STUDY OF THE CHANGES IN THE BLOOD PICTURE AFTER THE THERAPEUTIC USE OF I-131 IN THYROTOXICOSIS]. PODOBOVA NEPELOVA L Bratisl Lek Listy; 1963; 43():393-404. PubMed ID: 14058889 [No Abstract] [Full Text] [Related]
7. Prolonged diarrhea with near-fatal hemorrhage due to hypoprothrombinemia. SCHARFMAN WB; PROPP S Ann Intern Med; 1956 Feb; 44(2):385-91. PubMed ID: 13292847 [No Abstract] [Full Text] [Related]
8. Sprue with bleeding from hypoprothrombinemia. MOORE MJ; STRICKLAND WH; PRICHARD RW AMA Arch Intern Med; 1956 Jun; 97(6):814-6. PubMed ID: 13312726 [No Abstract] [Full Text] [Related]
9. [Exocrine function of the liver in experimental thyrotoxicosis]. BUDRUTDINOV MG Patol Fiziol Eksp Ter; 1961; 5():48-52. PubMed ID: 13874386 [No Abstract] [Full Text] [Related]
10. [Case of necrobiotic liver disease in thyrotoxicosis]. GRIGOLATO V; RAGAINI S Osp Maggiore; 1956 Oct; 44(10):572-89. PubMed ID: 13388362 [No Abstract] [Full Text] [Related]
12. Formation of prothrombin from autoprothrombin by means of liver mitochondria. ALKJAERSIG N; SEEGERS WH Am J Physiol; 1955 Oct; 183(1):111-3. PubMed ID: 13268645 [No Abstract] [Full Text] [Related]
14. [Hemorrhagic diathesis with a circulating antiprothrombin type of coagulant]. JANELE J; HRODEK O; HERMANSKY F Cas Lek Cesk; 1956 Mar; 95(11):296-300. PubMed ID: 13316799 [No Abstract] [Full Text] [Related]
15. [ANTITOXIC FUNCTION OF THE LIVER IN PATIENTS WITH THYROTOXICOSIS BEFORE AND AFTER RADIOACTIVE IODINE THERAPY]. DOZORETS IuL Zdravookhr Beloruss; 1963 Jun; 9():30-1. PubMed ID: 14078495 [No Abstract] [Full Text] [Related]
16. The liver in thyrotoxicosis. Dooner HP; Parada J; Aliaga C; Hoyl C Arch Intern Med; 1967 Jul; 120(1):25-32. PubMed ID: 6028694 [No Abstract] [Full Text] [Related]
17. [Origin of fatty degeneration of the heart, kidneys and liver in thyrotoxicosis]. FEDERLIN K Frankf Z Pathol; 1956; 67(3):265-71. PubMed ID: 13331012 [No Abstract] [Full Text] [Related]
18. [Disorder of the thrombocytic-vascular component of hemostasis in thyrotoxicosis]. PavlovskiÄ DP Probl Endokrinol (Mosk); 1977; 23(3):32-5. PubMed ID: 887630 [TBL] [Abstract][Full Text] [Related]
19. [Hemorrhagic diathesis (pseudo hemophilia) due to an specific inhibitor of factor VIII]. Dreyer MS; Omar Lebas J; Willer de Contardi N; Marti ML; Martinez Canaveri A Prensa Med Argent; 1970 Mar; 57(1):21-9. PubMed ID: 5454511 [No Abstract] [Full Text] [Related]